Search results for "Anticoagulation"
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low
A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://immattersacp.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022
Self-testing, self-dosage for anticoagulation safe, suitable option for some patients, study indicates
Self-testing and self-dosage of oral anticoagulation may be safe and suitable for patients of all ages with suitable health care support as backup, according to a meta-analysis.
https://immattersacp.org/weekly/archives/2011/12/06/1.htm
6 Dec 2011
Anticoagulation likely OK for stroke patients undergoing dental procedures
Stroke patients on blood thinners who undergo dental procedures can routinely continue aspirin or warfarin, according to level A recommendations issued by the American Academy of Neurology.
https://immattersacp.org/weekly/archives/2013/06/04/1.htm
4 Jun 2013
MKSAP Quiz: Multiple segmental pulmonary emboli
A 65-year-old man is diagnosed with multiple segmental pulmonary emboli in the right lung. He has no other medical problems, and he takes no medications. He is alert and engaged in shared decision making. After a physical exam and discussion with the patient, what is the appropriate treatment recommendation?
https://immattersacp.org/weekly/archives/2022/05/31/3.htm
31 May 2022
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
DOACs may be safe, effective for VTE prevention in patients with higher weight, BMI
Patients with first-time venous thromboembolism (VTE) who weighed 120 kg or more and had a body mass index (BMI) of 40 kg/m2 or more were not at higher risk for bleeding or recurrent VTE with direct-acting oral anticoagulants (DOACs) versus warfarin.
https://immattersacp.org/weekly/archives/2021/11/09/4.htm
9 Nov 2021
Approvals for an oral anticoagulant, generic esomeprazole
This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://immattersacp.org/archives/2015/04/fda.htm
1 Apr 2015
Cognitive impairment common after stroke
A scientific statement from the American Heart Association/American Stroke Association called for collaboration among primary care physicians, subspecialist doctors, and other health professionals to identify and manage cognitive problems after stroke.
https://immattersacp.org/weekly/archives/2023/05/09/4.htm
9 May 2023